Administration of phytosterols isolated from Aloe vera gel reduce visceral fat mass and improve hyperglycemia in Zucker diabetic fatty (ZDF) rats

Obesity Research and Clinical Practice

Volumn 2, Issue 4, 2008, Pages 239-245

  Misawa, Eriko ^a   Tanaka, Miyuki ^a   Nomaguchi, Kouji ^a   Yamada, Muneo ^a   Toida, Tomohiro ^a   Takase, Mitsunori ^a   Iwatsuki, Keiji ^a   Kawada, Teruo ^b  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b Graduate school of Agriculture   (Japan)

Author keywords

Aloe vera; Phytosterols; Type II diabetes; Visceral fat

Indexed keywords

CYCLOARTANOL; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; LOPHENOL; PHYTOSTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALOE VERA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG STRUCTURE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ZUCKER DIABETIC FATTY RAT;

ALOE VERA; ANIMALIA; RATTUS;

EID: 55749098476     PISSN: 1871403X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.orcp.2008.06.002     Document Type: Article

References (26)

1. Reynolds T., and Dweck A.C. Aloe vera leaf gel: a review update. J Ethnopharmacol 68 (1999) 3-37
2. Wu J.H., Xu C., Shan C.Y., and Tan R.X. Antioxidant properties and PC12 cell protective effects of APS-1, a polysaccharide from Aloe vera var. chinensis. Life Sci 78 (2006) 622-630
3. Vazquez B., Avila G., Segura D., and Escalamte B. Antiinflammatory activity of extracts from Aloe vera gel. J Ethnopharmacol 55 (1996) 69-75
4. Qui Z., Jones K., Wylie M., Jia W.Q., and Orndorf S. Modified Aloe barbadensis polysaccharide with immunregulatory activity. Planta Med 66 (2000) 152-156
5. Okyer A., Can A., Akev N., Baktir G., and Sutlupinar E. Effect of Aloe vera leaves on blood glucose level in type-I and type-II diabetic rat models. Phytother Res 15 (2001) 157-161
6. Rajasekaran D., Sivagnanam K., Ravi K., and Subramanian S. Hypoglycemic effect of Aloe vera gel on streptozotocin-induced diabetes in experimental rats. J Med Food 7 (2004) 61-66
7. Yongchaiyudha S., Rungpitarangsi V., Bunyapraphatsara N., and Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Phytomedicine 3 (1996) 241-243
8. Bunyapraphatsara N., Yongchaiyudha S., Rungpitarangsi V., and Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice. II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 3 (1996) 245-248
9. Tanaka M., Misawa E., Ito Y., Habara N., Nomaguchi K., Yamada M., et al. Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Biol Pharm Bull 29 (2006) 1418-1422
10. Leonard B.L., Watson R.N., Loomes K.M., Phillips A.R.J., and Cooper G.J. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterization of obese and lean phenotypes. Acta Diabetol 42 (2005) 162-170
11. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46 (1997) 3-10
12. Boden G., She P., Mozzoli Maria, Cheung P., Gumireddy K., Reddy P., et al. Free fatty acids produce insulin resistance and active the proinflammatory nuclear factor-κB pathway in rat liver. Diabetes 53 (2005) 3458-3465
13. Shimabukuro M., Zhou Y.-T., Levi M., and Unger R.H. Fatty acid-induced b cell apoptosis: A link between obesity and diabetes. Proc Natl Acad Sci USA 95 (1998) 2498-2502
14. Ikeda I., Konno R., Shimizu T., Ide R., Takahashi N., Kawada T., et al. Campest-5-en-3-on, an oxidized derivative of campesterol, activates PPARalpha, promotes energy consumption and reduces visceral fat deposition in rats. Biochim Biophys Acta 1760 (2006) 800-807
15. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
16. Gabriely I., Ma X.H., Yang Z.M., Atzmon G., Rajala M.W., Berg A.H., et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging. An adipokine-mediated process?. Diabetes 51 (2002) 2951-2958
17. Rosenberg D.E., Jabbour S.A., and Goldstein B.J. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment. Diabetes Obes Metab 7 (2005) 642-653
18. Rosenberg D.E., Jabbour S.A., and Goldstein B.J. Effectiveness of altering serum cholesterol levels without drugs. BUMC Proc 13 (2000) 351-355
19. Suzuki K., Tanaka M., Konno R., and Kaneko Y. Effects of 5-Campesteone (24-methylCholest-5-en-3-one) on the type 2 diabetes mellitus model animal C57BL/ksj-db/db mice. Horm Metab Res 34 (2002) 121-126
20. Konno R., Kaneko Y., Suzuki K., and Matsui Y. Effect of 5-campesteone (24-methylcholest-5-en-3-one) on Zucker diabetic rats as type 2 diabetes mellitus model. Horm Metab Res 37 (2005) 79-83
21. Xu Z., and Godber S. Purification and identification of components of γ-oryzanol in rice bran oil. J Agric Food Chem 47 (1999) 2724-2728
22. Yasukawa K., Akihisa T., Kimura Y., Tamura T., and Takido M. Inhibitory effects of cycloartenol ferulate, a component of rice bran, on tumor promotion in two-stage carcinogenesis in mouse skin. Biol Pharm Bull 21 (1998) 1072-1076
23. Rong N., Ausman L.M., and Nicolosi R.J. Oryzanol decreases cholesterol absorption and aortic fatty steaks in hamsters. Lipids 32 (1997) 303-309
24. Evans R.M., Barish G.D., and Wang Y.X. PPARs and the complex journey to obesity. Nat Med 10 (2004) 355-361
25. Eberle D., Heqarty B., Bossard P., Ferre P., and Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86 (2004) 839-848
26. Nomaguchi K, Tanaka M, Misawa E, Yamada M, Toida T, Iwatsuki K, et al. Aloe vera Extracts activate PPARs transcription activities. Proceedings of the fifth international conference on "Nutrition and Aging". ILSI 2007;91:63.